Search drugtarget on BioMed Central
1 items(s) found
Page 1 of 1
Articles per page: 25
IpsA, a novel LacI-type regulator, is required for inositol-derived lipid formation in Corynebacteria and Mycobacteria
BMC Biology 2013, 11:122 (30 December 2013)
Abstract | Full text | PDF | PubMed
Identification of IpsA as an essential transcriptional regulator of inositol anabolism and cell wall biosynthesis in the mycolata taxon of bacteria provides new targets for drug development against tuberculosis and diphtheria.
BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.